Increased isoprostane content in coronary plaques obtained from vulnerable patients

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 78, Issue 4-5, 2008, Pages 257-263

  Nishibe, A ^a   Kijima, Y ^a   Fukunaga, M ^b   Nishiwaki, N ^c   Sakai, T ^a   Nakagawa, Y ^a   Hata, T ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b KAGAWA UNIVERSITY HOSPITAL   (Japan)

^c KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIRECTIONAL ATHERECTOMY; FEMALE; HEART INFARCTION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; URINARY EXCRETION;

ACUTE DISEASE; AGED; ANGINA PECTORIS; ATHERECTOMY, CORONARY; CORONARY DISEASE; DINOPROST; FEMALE; HUMANS; ISOPROSTANES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

ANGINA;

EID: 44849103448     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2008.03.001     Document Type: Article

References (27)

1. Libby P. Molecular bases of the acute coronary syndromes. Circulation 91 (1995) 2844-2850
2. Fox K.A. Coronary disease. Acute coronary syndromes: presentation-clinical spectrum and management. Heart 84 (2000) 93-100
3. Waxman S., Ishibashi F., and Muller J.E. Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events. Circulation 114 (2006) 2390-2411
4. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
5. Kolodgie F.D., Narula J., Burke A.P., et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am. J. Pathol. 157 (2000) 1259-1268
6. Sluijter J.P., Pulskens W.P., Schoneveld A.H., et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 37 (2006) 235-239
7. Azumi H., Inoue N., Ohashi Y., et al. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1838-1844
8. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., and Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87 (1990) 9383-9387
9. Morrow J.D., Chen Y., Brame C.J., et al. The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab. Rev. 31 (1999) 117-139
10. Patrono C., and FitzGerald G.A. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2309-2315
11. Schwedhelm E., Bartling A., Lenzen H., et al. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 109 (2004) 843-848
12. Braunwald E. Unstable angina. A classification. Circulation 80 (1989) 410-414
13. Shinomiya K., Fukunaga M., Kiyomoto H., et al. A role of oxidative stress-generated eicosanoid in the progression of arteriosclerosis in type 2 diabetes mellitus model rats. Hypertens. Res. 25 (2002) 91-98
14. Kijima Y., Hashimura K., Matsu-ura Y., et al. Transcardiac 8-iso-prostaglandin F(2 alpha)generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress. Prostaglandins Leukot. Essent. Fatty Acids 64 (2001) 161-166
15. Kunishige M., Kijima Y., Sakai T., et al. Transient enhancement of oxidant stress and collagen turnover in patients with acute worsening of congestive heart failure. Circ. J. 71 (2007) 1893-1897
16. Gniwotta C., Morrow J.D., Roberts L.J., and Kuhn H. Prostaglandin F2-like compounds, F2-isoprostanes are present in increased amounts in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3236-3241
17. Oguogho A., Karanikas G., Kritz H., Riehs G., Wagner O., and Sinzinger H. 6-Oxo-PGF1alpha and 8-epi-PGF 2alpha in human atherosclerotic vascular tissue. Prostaglandins Leukot. Essent. Fatty Acids 60 (1999) 129-134
18. Pratico D., Iuliano L., Mauriello A., et al. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J. Clin. Invest. 100 (1997) 2028-2034
19. Mallat Z., Nakamura T., Ohan J., et al. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J. Clin. Invest. 103 (1999) 421-427
20. Mehrabi M.R., Ekmekcioglu C., Tatzber F., et al. The isoprostane, 8-epi-PGF2 alpha, is accumulated in coronary arteries isolated from patients with coronary heart disease. Cardiovasc. Res. 43 (1999) 492-499
21. Reilly M.P., Delanty N., Roy L., et al. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2 alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96 (1997) 3314-3320
22. Delanty N., Reilly M.P., Pratico D., et al. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95 (1997) 2492-2499
23. Asakura M., Ueda Y., Yamaguchi O., et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J. Am. Coll. Cardiol. 37 (2001) 1284-1288
24. Sugiyama M., Ohashi M., Takase H., Sato K., Ueda R., and Dohi Y. Effects of atorvastatin on inflammation and oxidative stress. Heart Vessels 20 (2005) 133-136
25. De Caterina R., Cipollone F., Filardo F.P., et al. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. Circulation 106 (2002) 2543-2549
26. Murphey L.J., Morrow J.D., Sawathiparnich P., Williams G.H., Vaughan D.E., and Brown N.J. Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives. Free Radic. Biol. Med. 35 (2003) 711-718
27. Austen W.G., Edwards J.E., Frye R.L., et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51 (1975) 5-40